Want to join the conversation?
$REGN 1Q15 10-Q: ETR was 72.5% and 62.2% for 1Q15 and 1Q14. 1Q15 ETR was negatively impacted by A, losses incurred in foreign jurisdictions with rates lower than the US federal statutory rate, B, non-tax deductible Branded Prescription Drug Fee, & C, expiration at the end of 2014 of the federal tax credit for increased research activities.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?